13F HOLDINGS REPORT
Artia Global Partners LP
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001937964-25-000004
Total Value
$395.1M
Positions
38
Other Managers
0
Confidential Omitted
No
Holdings (38)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ELI LILLY & CO | LLY | 94,887 | $78.4M | 19.84% |
| 2 | SOLENO THERAPEUTICS INC | SLNO | 498,473 | $35.6M | 9.01% |
| 3 | VERONA PHARMA PLC | 925050106 | 538,488 | $34.2M | 8.65% |
| 4 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 219,719 | $29.0M | 7.34% |
| 5 | ELI LILLY & CO | LLY | 30,000 | $24.8M | 6.27% |
| 6 | INSMED INC | INSM | 318,239 | $24.3M | 6.14% |
| 7 | MERUS N V | N5749R100 | 424,640 | $17.9M | 4.52% |
| 8 | PROTAGONIST THERAPEUTICS INC | PTGX | 333,851 | $16.1M | 4.09% |
| 9 | ARCELLX INC | ACLX | 229,085 | $15.0M | 3.80% |
| 10 | ASTRAZENECA PLC | AZN | 190,752 | $14.0M | 3.55% |
| 11 | BOSTON SCIENTIFIC CORP | BSX | 129,700 | $13.1M | 3.31% |
| 12 | ELI LILLY & CO | LLY | 15,000 | $12.4M | 3.14% |
| 13 | QUEST DIAGNOSTICS INC | DGX | 56,717 | $9.6M | 2.43% |
| 14 | ALNYLAM PHARMACEUTICALS INC | ALNY | 28,600 | $7.7M | 1.95% |
| 15 | SOLENO THERAPEUTICS INC | SLNO | 100,000 | $7.1M | 1.81% |
| 16 | ARGENX SE | ARGX | 11,311 | $6.7M | 1.69% |
| 17 | SOLENO THERAPEUTICS INC | SLNO | 92,500 | $6.6M | 1.67% |
| 18 | NUVALENT INC | NUVL | 90,745 | $6.4M | 1.63% |
| 19 | SCHOLAR ROCK HLDG CORP | SRRK | 172,185 | $5.5M | 1.40% |
| 20 | REVOLUTION MEDICINES INC | RVMDW | 104,190 | $3.7M | 0.93% |
| 21 | RHYTHM PHARMACEUTICALS INC | RYTM | 50,000 | $2.6M | 0.67% |
| 22 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 53,930 | $2.4M | 0.60% |
| 23 | VIKING THERAPEUTICS INC | VKTX | 90,279 | $2.2M | 0.55% |
| 24 | VIRIDIAN THERAPEUTICS INC | VRDN | 160,000 | $2.2M | 0.55% |
| 25 | TG THERAPEUTICS INC | TGTX | 54,515 | $2.1M | 0.54% |
| 26 | SOLENO THERAPEUTICS INC | SLNO | 26,600 | $1.9M | 0.48% |
| 27 | INTUITIVE SURGICAL INC | ISRG | 3,500 | $1.7M | 0.44% |
| 28 | EYEPOINT PHARMACEUTICALS INC | EYPT | 316,700 | $1.7M | 0.43% |
| 29 | NEUROCRINE BIOSCIENCES INC | NBIX | 14,700 | $1.6M | 0.41% |
| 30 | UNITED THERAPEUTICS CORP DEL | UTHR | 5,000 | $1.5M | 0.39% |
| 31 | XENON PHARMACEUTICALS INC | XENE | 40,000 | $1.3M | 0.34% |
| 32 | SOLENO THERAPEUTICS INC | SLNO | 17,800 | $1.3M | 0.32% |
| 33 | ASCENDIS PHARMA A/S | ASND | 7,440 | $1.2M | 0.29% |
| 34 | JANUX THERAPEUTICS INC | JANX | 38,100 | $1.0M | 0.26% |
| 35 | MEREO BIOPHARMA GROUP PLC | MREO | 421,359 | $948,058 | 0.24% |
| 36 | TRAVERE THERAPEUTICS INC | TVTX | 30,900 | $553,728 | 0.14% |
| 37 | CENTESSA PHARMACEUTICALS PLC | CNTA | 35,226 | $506,550 | 0.13% |
| 38 | ORUKA THERAPEUTICS INC | ORKA | 7,380 | $75,719 | 0.02% |